Molecular Characterization of Ciprofloxacin Resistance of Gonococcal Strains in Spain
- 1 May 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Sexually Transmitted Diseases
- Vol. 30 (5) , 395-398
- https://doi.org/10.1097/00007435-200305000-00004
Abstract
Background Over the past several years, the emergence of gonococcal isolates with intermediate or full resistance to fluoroquinolones has become a significant concern in several countries, including Spain. Goal The goal was to determine the occurrence of ciprofloxacin resistance among Neisseria gonorrhoeae strains in Spain during 2000 to 2001 and determine the frequency and patterns of mutations at gyrA, gyrB, and parC genes in these isolates. Study Design Eleven ciprofloxacin-resistant strains (with MICs ranging from 1 to 64 μg/mL) and two intermediate isolates (with MICs of 0.12 and 0.5 μg/mL) were found. Mutations were identified by polymerase chain reaction and direct sequencing of the amplified products. Results and Conclusions Alterations at Ser-91 and Asp-95 in GyrA were detected in all strains except one, an isolate for which the MIC was 0.12 μg/mL. Alterations in ParC were more variable, and there was no clear correlation between the number of parC mutations and the level of resistance. No alterations at gyrB gene associated with ciprofloxacin resistance were found. The resistance was distributed among different types of strains, suggesting that the increase in the incidence of ciprofloxacin-resistant strains in Spain was not exclusively due to the appearance of a single-strain outbreak.Keywords
This publication has 18 references indexed in Scilit:
- First Isolate of a Neisseria gonorrhoeae Strain Associated With an Ofloxacin Treatment Failure in SpainSexually Transmitted Diseases, 2001
- Molecular Basis of High-Level Ciprofloxacin Resistance in Neisseria gonorrhoeae Strains Isolated in Denmark from 1995 to 1998Antimicrobial Agents and Chemotherapy, 2001
- In Vitro Susceptibilities of 400 Spanish Isolates of Neisseria gonorrhoeae to Gemifloxacin and 11 Other Antimicrobial AgentsAntimicrobial Agents and Chemotherapy, 2000
- Susceptibilities of Neisseria gonorrhoeae Isolates Containing Amino Acid Substitutions in GyrA, with or without Substitutions in ParC, to Newer Fluoroquinolones and Other AntibioticsAntimicrobial Agents and Chemotherapy, 2000
- The epidemiology of global antibiotic resistance among Neisseria gonorrhoeae and Haemophilus ducreyiThe Lancet, 1998
- Fluoroquinolone resistance in gonorrhoea: how, where and so whatInternational Journal of STD & AIDS, 1998
- Fluoroquinolone Resistance in Neisseria gonorrhoeaeEmerging Infectious Diseases, 1997
- DNA gyrase mutations in quinolone-resistant clinical isolates of Neisseria gonorrhoeaeAntimicrobial Agents and Chemotherapy, 1995
- Neisseria gonorrhoeae acquires mutations in analogous regions of gyrA and parC in fluoroquinolone‐resistant isolatesMolecular Microbiology, 1994
- Analysis of genetic variability of penicillinase non-producing Neisseria gonorrhoeae strains with different levels of resistance to penicillinJournal of Medical Microbiology, 1992